Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Andrew Meds

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #152

Andrew Meds

A clean product page with a published price, in front of intake funnels that quote different numbers and sell a different program.

Visit Andrew Meds

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 70/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Andrew Meds still earns its place — a reader with time to reconcile three figures, because the price you are shown depends on which door you walk through.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results74
97Price honesty74
96Prescriber access69
88Formulary choice79
95Cancellation fairness56
93Member support62

Price, coverage & features

MetricCoreAge RxAndrew Meds
Verdict Score94/10070/100
GradeAC
Semaglutide$99/mo$199/mo (product-page rate; the intake funnels quote different figures, compounded)
Tirzepatide$149/mo$299/mo (product-page rate; no funnel reached today offered it, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoNo

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Andrew Meds

What we like

  • The compounding class is disclosed on the product pages themselves, written as 503(A) or 503(B) rather than left to the reader to guess
  • The prescribing practice is named in the footer of every page, with its own address, phone number and support address
  • Unusually, the Terms tell you outright that you may fill the prescription at any pharmacy of your choice
  • A toll-free number and a support address are published, and the account carries a self-serve cancellation control
  • Both molecules are listed at labeled weekly doses, with a microdose tier alongside

The caveats

  • Three semaglutide prices are live at once — the product page, the microdosing funnel and a four-week supply in a second funnel — and no page reconciles them
  • Every Get Started button on the semaglutide product page lands on a microdosing funnel, and the word microdosing appears nowhere on the marketing site
  • Both GLP-1 intakes ended by offering semaglutide only, so whether tirzepatide can actually be bought through the current funnels is unresolved
  • One funnel's plan ladder does not add up: its stated savings only reconcile if the per-month figures are read as totals, which the page never says
  • No pharmacy is named, no individual clinician is named, no NPI is published, and support hours are stated nowhere

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

A reader with time to reconcile three figures, because the price you are shown depends on which door you walk through.

Visit Andrew Meds Read the full Andrew Meds review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Andrew Meds does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.